000 | 01915nam a22003857a 4500 | ||
---|---|---|---|
008 | 240807s20242024 xxu||||| |||| 00| 0 eng d | ||
022 | _a2168-8184 | ||
024 | _aPMC11227298 [pmc] | ||
040 | _aOvid MEDLINE(R) | ||
099 | _a38975444 | ||
245 | _aUnmasking the Culprits: A Case of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis Presenting With Mouth Ulcers and Nosebleeds. | ||
251 | _aCureus. 16(6):e61822, 2024 Jun. | ||
252 | _aCureus. 16(6):e61822, 2024 Jun. | ||
253 | _aCureus | ||
260 | _c2024 | ||
260 | _fFY2025 | ||
260 | _p2024 Jun | ||
265 | _sepublish | ||
265 | _tPubMed-not-MEDLINE | ||
266 | _d2024-08-07 | ||
266 | _z2024/07/08 07:46 | ||
520 | _aHemophagocytic lymphohistiocytosis (HLH) is an aggressive syndrome of excessive immune activation. It usually occurs in children, mainly during the first year of life. Primary hemophagocytic lymphohistiocytosis is more common and usually occurs in immunocompromised patients. Secondary hemophagocytic lymphohistiocytosis, on the other hand, is less common, especially in immunocompetent patients. Here, we intend to present a case of a 55-year-old male patient who had no known immune deficiency, presented with epistaxis, and was found to have Epstein-Barr virus (EBV)-induced hemophagocytic lymphohistiocytosis. Copyright © 2024, Obeidat et al. | ||
546 | _aEnglish | ||
650 | _zAutomated | ||
651 | _aMedStar Washington Hospital Center | ||
656 | _aHematology/Oncology | ||
656 | _aInternal Medicine Residency | ||
657 | _aCase Reports | ||
657 | _aJournal Article | ||
700 |
_aNader, Kamyar _bMWHC |
||
700 |
_aObeidat, Ahmad _bMWHC _cInternal Medicine Residency _dMBBS |
||
790 | _aObeidat A, Al-Moussally F, Al Aruri DO, ALhomaimat E, Nader K | ||
856 |
_uhttps://dx.doi.org/10.7759/cureus.61822 _zhttps://dx.doi.org/10.7759/cureus.61822 |
||
942 |
_cART _dArticle |
||
999 |
_c14460 _d14460 |